Institutional Biosafety Committee

The Institutional Biosafety Committee (IBC) was established by the Marshall University Vice President for Research to ensure a safe working environment for the conduct of biological and biomedical research.

To learn more review the Marshall University Institutional Biosafety Committee Charter. 

Vincent Sollars, PhD
Chair, Institutional Biosafety Committee
Byrd Biotechnology Science Center 336N
304-696-7357
sollars@marshall.edu

Tracy Smith
Environmental Health and Safety Department
Sorrell Building Room 103
304-696-2993
tsmith@marshall.edu

Austin Hoffman
Biological Safety Officer
Sorrell Building Room 207
304-696-7357
hoffman55@marshall.edu
MU Safety and Health

Elaine Martino
Byrd Biotechnology Science Center 220A
304-696-2388
Radiation Safety Office
Chemical Safety

• Recombinant DNA Application [rev. 10/17/2022] [ Word ]
• rDNA Incident Reporting Form [ Word ]
• Workplace Injury/Illness Report Form
• Biohazardous Spill Occurrence Form [ PDF | Word ]
• Management of Spills [ PDF | Word ]
• Lab-specific Biosafety Manual Template [ Word ]

• BBSC Exposure Control Plan
• IBC Glove Use Policy
• Management Plan for Infectious Medical Waste Spill
• Lentiviral Vector Safe Handling
• MU IBC Ultraviolet Lamp Usage in Biological Safety Cabinets Policy
• IBC Guidance for Safe Handling of Cell Lines
• Biotech Center Infectious Waste Management Plan
• rDNA Applications Using Cell Lines and Human Samples
• Integrated Pest Management Plan (BBSC) 
• Bleach Policy

• Marshall University Human Gene Transfer Protocol Policy
• April 2019 Amendment of the NIH Guidelines (Human Gene Transfer Research)

• Biosafety Self-Audit Checklist
  
• Office of Science Policy
• NIH Guidelines for rDNA research
• NIH Guideline FAQs
• Investigator Responsibilities under the NIH Guidelines for Research Involving Recombinant DNA Molecules
• BMBL Appendix H - Working with Human, NHP and Other Mammalian Cells and Tissues
• ABSA Risk Group Classification for Infectious Agents
• State of WV Infectious Medical Waste Program
• OSHA Bloodborne Pathogen Fact Sheet
• OSHA Bloodborne Pathogen Standard (29.1910.1030)
• NIH Office of Science Policy
• Good Microbiological Practices
• Biosafety Level Summary
• Animal Experiments Covered Under the NIH

• Interim SARS-CoV-2 Biosafety Guidance

• Dual Use
• • Dual Use Research
  • Dual Use Research Brochure
  • Dual Use Research Guidance for Scientists in Non-Life Science Disciplines
  • Biotechnology in the Age of Terrorism: Confronting the Dual Use Dilemma
• Bloodborne Pathogen Training

• Biosafety Self-Audit Checklist
• MU User’s Guide to recombinant DNA guidelines
• NIH Intro to rDNA guidelines

• BMBL Guidelines for Work with Toxins of Biological Origin
• Pertussis Toxin Fact Sheet
• Select Agent Program
• Select Agent List
• MU Policy on Research Use of Acute Biological Toxins and Select Toxins
• Biological Toxin Select Agent Form
• List of Biological Toxins

• IBC Biosafety Course Policy
• CITI Biosafety Course Instructions

• Biosafety in Biomedical Laboratories and NIH rDNA regulations (June 1, 2022) 
• Chemical Safety
• • Chemical safety training can now be obtained using a CITI course. In question six select Laboratory Chemical Safety when adding a new course. 
• General Lab Biosafety June 2, 2021